Related Experiment Video
Updated: Jun 23, 2026
07:41
Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
Heterogeneous biomedical database integration using a hybrid strategy: a p53 cancer research database
Vadim Y Bichutskiy1, Richard Colman, Rainer K Brachmann
1Department of Computer Science, Institute for Genomics and Bioinformatics, University of California, Irvine, California 92697, USA.
Cancer Informatics
|May 22, 2009
Summary
Integrating diverse cancer research data is crucial for finding new treatments. The Cancer Research DataBase (CRDB) demonstrates a hybrid approach to combine various data types, aiding the search for drugs targeting mutated p53 in cancer.
Area of Science:
- Biomedical Informatics
- Cancer Research
- Database Integration
Background:
- Multidisciplinary life science research necessitates integrating heterogeneous databases.
- The tumor suppressor p53 is frequently mutated in human cancers, making it a key target for cancer treatment.
- Developing small molecules to restore native function to mutated p53 is a significant goal in cancer therapy.
Purpose of the Study:
- To present the Cancer Research DataBase (CRDB) as a solution for integrating diverse cancer research data.
- To illustrate a hybrid data integration strategy combining mediation and data warehousing.
- To provide a design methodology for similar biomedical data integration systems.
Main Methods:
- Designed the Cancer Research DataBase (CRDB) to support small molecule drug discovery for cancer.
- Integrated various data types including small molecule data, computational docking results, functional assays, and protein structures.
- Employed a hybrid data integration strategy, merging mediation and data warehousing approaches.
Main Results:
- The CRDB successfully integrated heterogeneous data relevant to cancer research and drug discovery.
- The hybrid strategy proved effective for managing complex, multidisciplinary data in biomedicine.
- Demonstrated the viability of the CRDB's design for enhancing data sharing and productivity.
Conclusions:
- The hybrid data integration strategy, as exemplified by the CRDB, is a viable and effective approach for biomedical research.
- Improved data sharing through integrated databases can accelerate cancer research and increase the likelihood of successful outcomes.
- The CRDB and its design principles offer a valuable resource for the scientific community, with downloadable code and schemas.
